We have previously described expression of COX-2 in primary medulloblastoma tissues and patient-derived cell cultures, and demonstrated that COX-2 inhibition reduces the growth of subcutaneous medulloblastoma xenografts21, 24. Here, PTGS2 is linked to medulloblastoma.